Introduction. Several years after the end of the COVID-19 pandemic, the consequences of severe forms of the disease continue to have a significant impact on the condition of geriatric patients. Aim: to study the severity of dyspnea, fatigue, depression, cognitive deficit, adherence to lipid-lowering therapy and the incidence of sarcopenic syndromes in geriatric patients with a history of COVID-19. Materials and methods: a cross-sectional observational anonymous study involved 185 patients of the Saratov Veterans Hospital (mean age 77.29 ± 6.99 years), of whom 129 (69.73%) had COVID-19. To assess the severity of dyspnea, the mMRC and Borg scales were used; fatigue was identified using the FSS questionnaire; cognitive deficit - using the McNair and Kahn questionnaire; depression was established based on the results of the GDS-15 scale. The Morisky-Green questionnaire was used to assess adherence to lipid-lowering therapy. Sarcopenia and sarcopenic obesity were identified according to the 2018 European Sarcopenia Working Group consensus and the 2022 European Association for Clinical Nutrition and Metabolism algorithm. Results. Among patients with a history of severe COVID-19, clinically significant dyspnea of greater severity was noted according to two scales: mMRC and Borg. Depression was also detected with a higher frequency (52.31%) in individuals with a history of severe COVID-19. No statistically significant differences in cognitive dysfunction and fatigue were obtained when comparing patients who had COVID-19 and those who avoided infection (p> 0.05). Adherence to lipid-lowering therapy, however, was statistically significantly lower in patients with a history of COVID-19, regardless of the severity of the disease 2 (1; 2.5), p = 0.005. Among individuals who had a severe case of the new coronavirus infection, patients with sarcopenic obesity prevailed (52.31%). Conclusions. Despite the end of the COVID-19 pandemic, its consequences continue to affect the condition of the elderly, exerting a multimodal negative impact on a number of the most important components of healthy aging: physical, emotional status, adherence to vital therapy. The high prevalence of sarcopenic obesity among individuals with severe COVID-19 suggests that this geriatric syndrome is a prognostically unfavorable predictor associated with increased hospitalization, need for respiratory support, and potentially adverse outcomes in the development of infectious and respiratory diseases in elderly patients.